OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of allergen immunotherapy supporting its disease-modifying effect
Roxana Silvia Bumbăcea, Rama Boustani, Carmen Panaitescu, et al.
Immunotherapy (2022) Vol. 14, Iss. 8, pp. 627-638
Closed Access | Times Cited: 9

Showing 9 citing articles:

Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
Diego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 960-960
Open Access | Times Cited: 7

Advancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1316-1316
Open Access | Times Cited: 5

Confronting allergies: strategies for combating pollution and safeguarding our health
Shakti Prasad Pattanayak, Suman Kalyan Dinda, Shreyasee Hazra, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access

Preventive allergen immunotherapy with inhalant allergens in children
Varsha Dwivedi, Sonja Kopanja, Klara Schmidthaler, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2065-2087
Open Access | Times Cited: 3

Allergen Immunotherapy for the Prevention and Treatment of Asthma
Thierry Batard, Camille Taillé, Laurent Guilleminault, et al.
Clinical & Experimental Allergy (2024)
Open Access | Times Cited: 2

Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden
Lars‐Olaf Cardell, Thomas Sterner, Waqas Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

What is disease modification and is this concept even helpful?
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 1-4
Closed Access | Times Cited: 1

Long-term tolerance and efficacy of venom immunotherapy after an episode of Crohn’s disease and ankylosing spondylitis after up-dosing
M. Winkler, Franziska Ruëff, Silvan Lange, et al.
Allergologie select (2024) Vol. 8, Iss. 01, pp. 332-335
Closed Access

Page 1

Scroll to top